PMID- 29035111 OWN - NLM STAT- MEDLINE DCOM- 20180529 LR - 20180529 IS - 1876-2891 (Electronic) IS - 1876-2883 (Linking) VI - 8 IP - 5 DP - 2017 Oct 13 TI - Identification of atopic dermatitis phenotypes with good responses to probiotics (Lactobacillus plantarum CJLP133) in children. PG - 755-761 LID - 10.3920/BM2017.0034 [doi] AB - The therapeutic effect of probiotics in atopic dermatitis (AD) remains controversial and varies according to the individual patient. We aimed to identify a population of AD patients with a good clinical response to probiotic treatment. We recruited 76 children with a median age of 7.1 years who suffered from moderate to severe AD. After a 2-week washout period, all patients were given Lactobacillus plantarum CJLP133 at a dosage of 1x10(10) colony-forming units once a day for 12 weeks. We measured eosinophil counts in the peripheral blood, the proportion of CD4(+)CD25(+)Foxp3(+) regulatory T (Treg) cells in CD4(+) T cells, serum total immunoglobulin E (IgE) levels, and specific IgE against common allergens before the start of the treatment (T1) and at discontinuation (T2). Responders were defined as patients with at least a 30% reduction in the SCORing of AD (SCORAD) index after treatment. There were 36 responders and 40 non-responders after probiotic treatment. The median SCORAD was reduced from 29.5 (range 20.6-46.3) at T1 to 16.4 (range 6.3-30.8) at T2 in the responder group (P<0.001). In multivariable logistic regression analysis, a good clinical response was significantly associated with high total IgE levels (aOR 5.1, 95% CI 1.1-23.6), increased expression of transforming growth factor (TGF)-beta (aOR 4.6, 95% CI 1.3-15.9), and a high proportion of Treg cells in CD4(+) T cells (aOR 3.7, 95% CI 1.1-12.7) at T1. In the responder group, the proportion of Treg cells was significantly increased after 12 weeks of treatment (P=0.004), while TGF-beta mRNA expression was decreased (P=0.017). Our results suggest that a subgroup of patients with a specific AD phenotype showing an immunologically active state (high total IgE, increased expression of TGF-beta, high numbers of Treg cells) may benefit from probiotic treatment with L. plantarum CJLP133. FAU - Kim, J AU - Kim J AD - 1 Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnamgu, Seoul 06351, Republic of Korea. AD - 2 Environmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, Republic of Korea. FAU - Lee, B S AU - Lee BS AD - 2 Environmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, Republic of Korea. FAU - Kim, B AU - Kim B AD - 3 Beneficial Microbes R&D Center, CJ CheilJedang Corporation, Suwon, Republic of Korea. FAU - Na, I AU - Na I AD - 2 Environmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, Republic of Korea. FAU - Lee, J AU - Lee J AD - 2 Environmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, Republic of Korea. FAU - Lee, J Y AU - Lee JY AD - 1 Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnamgu, Seoul 06351, Republic of Korea. AD - 2 Environmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, Republic of Korea. FAU - Park, M R AU - Park MR AD - 4 Department of Pediatrics, Sung-Ae Hospital, Seoul, Republic of Korea. FAU - Kim, H AU - Kim H AD - 5 Biostatistics and Clinical Epidemiology Center, Samsung Medical Center, Seoul, Republic of Korea. FAU - Sohn, I AU - Sohn I AD - 5 Biostatistics and Clinical Epidemiology Center, Samsung Medical Center, Seoul, Republic of Korea. FAU - Ahn, K AU - Ahn K AD - 1 Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, 81 Irwon-ro, Gangnamgu, Seoul 06351, Republic of Korea. AD - 2 Environmental Health Center for Atopic Diseases, Samsung Medical Center, Seoul, Republic of Korea. LA - eng PT - Journal Article PL - Netherlands TA - Benef Microbes JT - Beneficial microbes JID - 101507616 RN - 0 (Biomarkers) RN - 0 (Immunologic Factors) SB - IM MH - Adolescent MH - Biomarkers/blood MH - Child MH - Child, Preschool MH - Dermatitis, Atopic/*pathology/*therapy MH - Female MH - Humans MH - Immunologic Factors/*administration & dosage MH - Infant MH - Lactobacillus plantarum/*growth & development MH - Male MH - Probiotics/*administration & dosage MH - Severity of Illness Index MH - Treatment Outcome OTO - NOTNLM OT - Lactobacillus plantarum OT - atopic dermatitis OT - probiotics OT - regulatory T cells OT - response EDAT- 2017/10/17 06:00 MHDA- 2018/05/31 06:00 CRDT- 2017/10/17 06:00 PHST- 2017/10/17 06:00 [entrez] PHST- 2017/10/17 06:00 [pubmed] PHST- 2018/05/31 06:00 [medline] AID - 10.3920/BM2017.0034 [doi] PST - ppublish SO - Benef Microbes. 2017 Oct 13;8(5):755-761. doi: 10.3920/BM2017.0034.